United States Nuclear Regulatory Commission - Protecting People and the Environment

Public Meeting Schedule: Meeting Details

[ New Search ]
Meeting info
To solicit comments from the public and stakeholders on the NRC's evaluation of the training and experience (T&E) requirements for a physician to become an authorized user for medical uses under Subpart E, “Unsealed Byproduct Material—Written Directive Required,” of Title 10 of the Code of Federal Regulations (10 CFR) Part 35, “Medical Use of Byproduct Material.” Notice soliciting comments was published in the Federal Register on October 29, 2018 (83 FR 54380).
Meeting Feedback
Meeting Dates and Times
10:00AM - 12:00PM

Webinar Link:https://attendee.gotowebinar.com/register/6104416384032879106
Webinar Meeting Number:255-273-083
Webinar Password:N/A
Sarah Lopas

Participation Level
Category 3
NRC Participants
Office of Nuclear Material Safety and Safeguards
External Participants
Docket Numbers - Facility Names
Related Documents
ML18302A095 - Federal Register Notice 83 FR 54380 Training and Experience Requirements for Different Categories of Radiopharmaceuticals.

ML19011A462 - Slideshow Presentation for January 22, 2019 Public Comment Webinar on the NRC Staff's Evaluation of Training and Experience for Administering Certain Radiopharmaceuticals.

ML18135A277 - SECY-18-0084: Staff Evaluation of Training and Experience Requirements Administering Different Categories of Radiopharmaceuticals in Response to SRM-M170817

ML19015A162 - 01/22/2019 Public Meeting (WEBINAR) to Accept Comments on the NRC's Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 FR 54380)

Bridge Number: 8884525182
Passcode: 4067508
Federal Register notice (83 FR 54380) can be accessed at https://www.gpo.gov/fdsys/pkg/FR-2018-10-29/pdf/2018-23521.pdf and also under "Related Documents," above. Additional meetings on this topic will be held on November 14, 2018 (webinar-only); December 11, 2018 (in-person meeting at NRC Headquarters and webinar); and January 10, 2019 (in-person meeting at NRC Headquarters and webinar).